FDA approves cancer drug based on genetic type, not organ of origin
Wednesday, May 24, 2017 - 12:02
in Health & Medicine
The FDA announced Tuesday that, for the first time, it approved a cancer drug based on disease genetics rather than the body part where the cancer originated.